01 1Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
01 1DAPTOMYCIN (PROCESS II)
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-09-04
Pay. Date : 2020-07-29
DMF Number : 34721
Submission : 2020-03-31
Status : Active
Type : II
20
Livzon Group Fuzhou Fuxing Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DAPTOMYCIN (PROCESS II), with a corresponding US DMF Number 34721.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 04, 2020, and payment made on July 29, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
